InvestorsHub Logo

doogdilinger

01/04/18 10:02 AM

#32040 RE: mopar44o #32039

Agreed, they're gonna need increased SeroquelXR sales and hopefully at least 1 of Pristiq or Lamictal finally getting FDA approved...or they're gonna have to find a way to partner Regabatin, their Oxy NDA candidate or PODRAS.

And even if they get any of the above good drivers in motion they've got to get off their collective butts so to speak, and start telling their story to market...otherwise the market apathy will continue unabated and not only will their NAZ listing be in jeopardy so will be Dr. Odidi's lifelong dream.

Why they continue to not bother doing a single thing to tell their story to market is beyond me...if they don't believe in providing a blueprint to the masses then the masses sure as hell won't believe in taking a position in their future right!

fabius

01/04/18 12:00 PM

#32043 RE: mopar44o #32039

Exactly my point mopar44,

the issue 5mln shares = roughly 15% dilution

>> market cap on paper goes up 15%

>> the paradise of shorters/manipulators is alive again: the shares price does down at least 30% over a 3 weeks period.

>> net-net mkt cap goes down, so even if they regain compliance for the 1.00$ per share requirement, they miss big the mkt cap threshold.


completely different story if they issue 5mln shares to, say, Purdue, contextually signing an agreemnt for Rexista 2.0 and prodras.

this is jmho, with a little support from what happened after the recent offer.